AMSBIO announce StemFit® for MSC – a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells.

StemFit® for Mesenchymal Stem Cells (MSC) is the latest addition to the StemFit® family of stem cell media.  It is a chemically defined and human/animal origin free medium, optimized for the isolation and culture of MSCs from bone marrow (BM-MSC), umbilical cord (UC-MSC), and adipose (ADSC) under serum-free, human platelet lysate free conditions.

The fully chemically defined formulation of StemFit® for MSC minimizes lot-to-lot variation and enables highly consistent and superior cell expansion compared to serum containing media. Containing no animal or human-derived components minimizes risk of immunogenic contamination making StemFit® for MSC also extremely safe to use.

Extensively tested, StemFit® for MSC offers exceptional cell expansion with high levels of marker expression and differentiation potential. For best results, AMSBIO recommend using StemFit® for MSC with iMatrix-511 as a cell culture substrate.

For further information on StemFit® for Mesenchymal Stem Cells (MSC) please visit https://www.amsbio.com/stemfit-for-mesenchymal-stem-cells/ or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / [email protected]. AMSBIO will be exhibiting at the German Stem Cell Network Virtual Conference from the 23rd-25th September 2020 – for more information please visit https://www.amsbio.com/events/gscn-2020/.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.

AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.

For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues.

The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.

Source